What Is PRP Injection for Spine Pain? A Patient’s Guide

PRP (platelet-rich plasma) injection for the spine is a non-surgical, regenerative procedure in which platelets concentrated from the patient’s own blood are injected into a damaged spinal structure—such as a facet joint, intervertebral disc, or ligament—to release growth factors that activate tissue repair. Approximately 47% of patients achieve ≥50% pain relief at 6 months. It is one of several non-surgical spine treatment options available to appropriate candidates.

Back pain affects 80% of people at some point in their lifetime and is the leading cause of disability worldwide. For patients who have exhausted conservative measures but want to avoid surgery, regenerative biologics like PRP represent a meaningful middle path. Understanding exactly what PRP is, how it works in the spine, what the evidence says, and how it compares to other biologic options helps patients make genuinely informed decisions.

This guide covers the definition of PRP injection for the spine in full clinical detail, its mechanism of action, appropriate candidacy, the evidence base, and a direct comparison to related interventions including biologic disc repair (intra-annular fibrin injection) and epidural steroid injections. For a broader look at where PRP fits within the full spectrum of options, see our non-surgical spine treatment overview.

Definition (Expanded)

PRP stands for platelet-rich plasma. Platelets are small blood cells best known for their role in clotting, but they also carry dense granules packed with growth factors—proteins that signal other cells to migrate, proliferate, and begin repair. In their normal concentration in blood, platelets number approximately 150,000–400,000 per microliter. PRP preparation concentrates platelets to three to eight times that baseline, producing a potent autologous (from the patient’s own body) biologic concentrate.

When applied to spinal structures, PRP is not simply a pain-blocking injection. It is a repair-signaling injection. The growth factors released—including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), and insulin-like growth factor (IGF)—trigger a healing cascade in tissue that, due to poor blood supply or chronic degeneration, has stalled in a state of incomplete repair.

The term “PRP injection for the spine” encompasses several distinct applications: facet joint PRP, intradiscal PRP, and peri-ligamentous PRP. Each targets a different anatomical source of pain. The procedure is always outpatient, image-guided, and uses the patient’s own blood—eliminating the risk of allergic reaction or disease transmission from donor material.

How It Works

The PRP procedure follows a consistent protocol regardless of the spinal target:

1. Blood draw. A small volume of blood (typically 15–60 mL) is drawn from the patient’s arm, similar to a standard lab draw.
2. Centrifugation. The blood is placed in a centrifuge and spun at a calibrated speed that separates blood components by density. Red blood cells settle to the bottom, the buffy coat (platelet and white blood cell layer) sits in the middle, and platelet-poor plasma floats on top.
3. Concentration. The platelet-rich layer is extracted, yielding a concentrate with 3–8x the baseline platelet count.
4. Image-guided injection. Under fluoroscopic or ultrasound guidance, the PRP is injected precisely into the target structure—facet joint capsule, nucleus pulposus, annular region, or periligamentous tissue.
5. Growth factor release. Platelets degranulate at the injection site, releasing growth factors. These signals attract fibroblasts and chondrocytes (repair cells), stimulate collagen synthesis, reduce inflammatory cytokines, and promote new blood vessel formation in the target tissue.

The process typically takes 60–90 minutes from blood draw to post-procedure recovery. Most patients experience mild soreness at the injection site for 48–72 hours as the inflammatory phase of healing initiates. This is a normal biological response, not a complication.

Why It Matters: The Case for Regenerative Biologics in Spine Care

The statistics that frame spine treatment decisions are stark. Roughly 40% of back surgeries do not achieve the patient’s desired outcome. That figure represents hundreds of thousands of patients each year who undergo the risks, recovery time, and cost of spinal surgery without reaching their functional goals.

PRP does not replace surgery in cases of true structural instability, neurological emergency, or advanced deformity. But for the large population of patients with pain-generating but structurally manageable conditions—facet arthritis, early disc degeneration, ligament laxity—PRP offers a biologically active, non-destructive alternative to both prolonged pharmacological management and elective surgery.

The comparison to epidural steroid injections (ESI) is important here. ESIs reduce inflammation but provide no structural repair signal. They are appropriate for acute radiculopathy and nerve root inflammation, but their benefit is time-limited and their repeated use carries documented risks. PRP, by contrast, acts on the tissue’s repair mechanism rather than simply suppressing the inflammatory signal.

For patients with confirmed annular tears—where a structural disc defect is driving pain—a more targeted option exists: intra-annular fibrin injection (biologic disc repair). This procedure places a fibrin biologic directly inside the disc to physically seal the annular defect. Long-term data from fibrin studies show VAS pain scores falling from 72.4 mm at baseline to 33.0 mm at 104 weeks, with 70% patient satisfaction at the 2+ year follow-up mark. PRP and fibrin injection address different pathologies; understanding the distinction is essential to matching the right tool to the right diagnosis. See our detailed comparison: PRP vs. Fibrin Injection for Non-Surgical Spine Treatment.

Key Components: Conditions Treated with PRP in the Spine

Facet Joint Arthritis

Facet joints are the paired posterior joints that link vertebrae. Like any synovial joint, they are subject to osteoarthritis. PRP delivered into the facet joint capsule supplies growth factors to cartilage and synovial tissue that have limited self-repair capacity due to poor vascularity. Multiple studies demonstrate that intra-articular PRP outperforms corticosteroid injections for facet-mediated pain at 3- and 6-month follow-up intervals.

Intervertebral Disc Degeneration

The nucleus pulposus (inner disc) is avascular in adults. Degeneration progresses in part because repair cells cannot be efficiently recruited to a bloodless environment. Intradiscal PRP introduces growth factors directly into the disc space, bypassing the vascular limitation. Published data show approximately 47% of patients achieve ≥50% pain relief at 6 months with intradiscal PRP. Patient selection is critical: discs with severe collapse or end-stage degeneration show less response than moderate-stage degeneration.

Spinal Ligament Laxity and Injury

Ligaments of the posterior spinal complex—supraspinous, interspinous, and iliolumbar ligaments—can sustain chronic micro-tears from injury or repetitive loading. PRP applied to these structures stimulates fibroblast activity and collagen remodeling, tightening lax ligamentous restraints and reducing the segmental microinstability that contributes to chronic low back pain.

Sacroiliac Joint Dysfunction

The sacroiliac (SI) joint is a common but frequently overlooked pain generator. PRP injected into the SI joint follows the same mechanism as facet joint treatment—delivering repair signals to cartilage and capsular tissue in a joint with limited vascularity.

PRP vs. Biologic Disc Repair vs. Epidural Steroid Injection: A Clinical Comparison

For a full evidence-based ranking of non-surgical options, see: Non-Surgical Spine Treatments Ranked by Evidence. Patients weighing biologic options against surgical alternatives can also review: Spinal Fusion Alternatives.

Related Terms

• Autologous biologic: Any treatment derived entirely from the patient’s own tissues, eliminating donor-related risk.
• Platelet-rich plasma (PRP): Blood plasma processed to contain a higher concentration of platelets than found in whole blood.
• Growth factors: Proteins secreted by platelets—including PDGF, TGF-β, VEGF, and IGF—that regulate cell migration, proliferation, and differentiation during tissue repair.
• Intradiscal injection: Any injection delivered directly into the nucleus pulposus or annular region of an intervertebral disc.
• Intra-annular fibrin injection (biologic disc repair): A targeted regenerative procedure that delivers a fibrin biologic into the annular defect of a damaged intervertebral disc to seal the tear and restore structural integrity.
• Annular tear repair: The process of closing a defect in the outer fibrous ring (annulus fibrosus) of the disc—achievable through biologic disc repair methods.
• Facet joint injection: Delivery of a therapeutic agent into the synovial capsule of the posterior facet joint; can be performed with corticosteroids or with PRP.

Common Misconceptions About PRP for Spine Pain

Misconception 1: PRP is experimental with no real evidence.

PRP has an expanding body of peer-reviewed clinical data supporting its use in orthopedic and spine applications. The approximately 47% rate of ≥50% pain relief at 6 months for intradiscal PRP is drawn from published randomized and controlled studies. While PRP is not yet covered by most insurance carriers, lack of insurance coverage reflects reimbursement policy decisions—not absence of evidence.

Misconception 2: PRP and biologic disc repair are the same procedure.

They are not. PRP delivers concentrated growth factors to broad tissue targets, signaling the body’s own repair processes. Intra-annular fibrin injection places a structural biologic—fibrin—directly inside the disc to seal a specific anatomical defect (the annular tear). PRP addresses healing signaling; fibrin disc treatment addresses structural sealing. A patient with an annular tear and concordant discogenic pain is a candidate for fibrin injection. See: Signs You Can Avoid Spine Surgery.

Misconception 3: PRP works immediately.

PRP initiates a biological repair process. Patients experience an initial inflammatory phase (48–72 hours of soreness), followed by a proliferative phase, and finally a remodeling phase. Full clinical benefit is typically observed at 6–12 weeks post-injection. Patients who assess the procedure at one week and report no improvement are evaluating before the therapeutic window opens.

Misconception 4: Anyone with back pain qualifies for PRP.

PRP is most appropriate for specific, confirmed pain generators in the spine—facet arthritis, intervertebral disc degeneration, ligament injury—in patients with intact structural anatomy who do not require surgical stabilization. Proper candidacy requires imaging review, clinical examination, and in some cases diagnostic injections to confirm the pain generator before PRP is applied. For a broader non-surgical pathway guide, see: Conservative Spine Care Guide.

Frequently Asked Questions

What is a PRP injection for the spine?

A PRP (platelet-rich plasma) injection for the spine is a non-surgical, regenerative procedure. A small amount of the patient’s blood is drawn, spun in a centrifuge to concentrate the platelets, and then injected into the damaged spinal structure—such as a facet joint, intervertebral disc, or spinal ligament. The concentrated platelets release growth factors that signal the body to begin tissue repair and reduce inflammation.

How effective is PRP for spine pain?

Published clinical data shows approximately 47% of patients treated with PRP achieve at least 50% pain relief at 6 months. Results vary based on the specific structure being treated, the severity of degeneration, and whether PRP is combined with other conservative care strategies. PRP is most effective for facet joint arthritis, early-to-moderate disc degeneration, and spinal ligament injuries.

What is the difference between PRP and biologic disc repair?

PRP and biologic disc repair (intra-annular fibrin injection) are both non-surgical biologic treatments, but they work through different mechanisms. PRP delivers concentrated growth factors broadly to stimulate the body’s healing cascade—useful for facet joints, ligaments, and general disc inflammation. Intra-annular fibrin injection is a targeted annular tear repair that places a fibrin biologic directly inside the disc to physically seal the annular defect and restore disc integrity. Long-term fibrin studies show a VAS reduction from 72.4 mm at baseline to 33.0 mm at 104 weeks, with 70% patient satisfaction at the 2+ year follow-up.

Am I a candidate for PRP spine injection?

Good candidates generally include patients with facet joint arthritis, mild-to-moderate disc degeneration, spinal ligament laxity, or chronic low back pain who have not responded fully to physical therapy, medication management, or epidural steroid injections. Patients with active infection, certain blood disorders, or advanced structural instability requiring surgical stabilization are typically not candidates. A thorough evaluation—including imaging review—is required to determine appropriateness.

Is PRP injection for the spine covered by insurance?

PRP injection for the spine is currently considered investigational by most major insurance carriers and is not covered under standard health insurance plans. Patients typically pay out-of-pocket. Costs vary by provider and treatment protocol. Many patients find that the cost compares favorably to prolonged medication management or surgical intervention, particularly when recovery time and indirect costs are factored in.

Sources

1. Levi D, Horn S, Tyszko S, et al. Intradiscal platelet-rich plasma injection for chronic discogenic low back pain: preliminary results from a prospective trial. Pain Med. 2016;17(6):1010–1022.
2. Akeda K, Ohishi K, Masuda K, et al. Intradiscal injection of autologous platelet-rich plasma releasate to treat discogenic low back pain. Asian Spine J. 2017;11(3):380–389.
3. Wu J, Du Z, Lv G, et al. A new technique for the treatment of lumbar facet joint syndrome using intra-articular injection with autologous platelet-rich plasma. Pain Physician. 2016;19(8):617–625.
4. Global Burden of Disease Study 2019 Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories. Lancet. 2020;396(10258):1204–1222.
5. Chou R, Baisden J, Carragee EJ, et al. Surgery for low back pain: a review of the evidence for an American Pain Society Clinical Practice Guideline. Spine. 2009;34(10):1094–1109.
6. Vos T, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–2196.